Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Basic & Clinical Pharmacology & Toxicology|June 19, 2015
Effect of Truncating AUC at 12, 24 and 48 hr When Evaluating the Bioequivalence of Drugs with a Long Half-LifeIsabel Moreno, Dolores Ochoa, Manuel Román, et al.
Basic & Clinical Pharmacology & Toxicology|January 26, 2016
Utility of Pilot Studies for Predicting Ratios and Intrasubject Variability in High-Variability DrugsIsabel Moreno, Dolores Ochoa, Manuel Román, et al.
Pain Practice : the Official Journal of World Institute of Pain|October 29, 2022
Off-label pharmacological treatment for neuropathic pain: A Delphi study by the Spanish Pain Society Neuropathic Pain Task ForceAncor Serrano, Rafael Gálvez, Elena Paremés, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social|January 29, 2016
[Diagnostic strategies in the Tuberculosis Clinic of the Hospital General La Raza National Medical Center]Alberto Alejandro Flores-Ibarra, María Dolores Ochoa-Vázquez, Georgina Alejandra Sánchez-Tec
Human Psychopharmacology|April 6, 2013
Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjectsTeresa Cabaleiro, Rosario López-Rodríguez, Dolores Ochoa, et al.
BMC Pharmacology & Toxicology|July 27, 2020
Effect of food on the pharmacokinetics of omeprazole, pantoprazole and rabeprazoleDolores Ochoa, Manuel Román, Teresa Cabaleiro, et al.
Medicina (Kaunas, Lithuania)|May 28, 2022
Update on Interventional Management of Neuropathic Pain: A Delphi Consensus of the Spanish Pain Society Neuropathic Pain Task ForceAncor Serrano-Afonso, Rafael Gálvez, Elena Paramés, et al.
Autoimmune Diseases|September 27, 2013
Genetics of psoriasis and pharmacogenetics of biological drugsRocío Prieto-Pérez, Teresa Cabaleiro, Esteban Daudén, et al.
Pharmacogenomics|October 4, 2013
Pharmacogenetics of topical and systemic treatment of psoriasisRocío Prieto-Pérez, Teresa Cabaleiro, Esteban Daudén, et al.
Pageof 12